Comprehensive Analysis of the “Radiopharmaceuticals Market” Top Venders 2018: Cardinal Health, GE Healthcare, Bayer, Nordion Inc, Advanced Accelerator Applications, MallinckrodtPlc., Lantheus Medical Imaging & More

DatabridgemarketResearch brings to you a Global Radiopharmaceuticals Market Research report is a synopsis in the Top Competitors of industry which is changing day by day in the forecast period of 2017-2024.

The report contains all the market drivers and restrains of the Global Radiopharmaceuticals Market which are derived from SWOT analysis, the report also contains the Porter's Five Forces Analysis which informs about the threat of new entrants, threat of substitutes, Bargaining power of customers, bargaining power of suppliers, Industry rivalry to the organization.

Download PDF Sample Copy of Report Visit @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-radiopharmaceuticals-market

Top Challengers:

• Cardinal Health Inc.
• MallinckrodtPlc.
• GE Healthcare
• Lantheus Medical Imaging Inc.
• Bayer AG
• Bracco Imaging SpA
• Eczacibasi-Monrol Nuclear Products
• Nordion Inc.
• Advanced Accelerator Applications S.A.
• IBA Molecular Imaging
• Actinium Pharmaceuticals Inc.,
• Among others.

Market Definition:

Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent. Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy.

The procedures and facilities for the production, use, and storage of radiopharmaceuticals are subject to licensing by national or regional authorities. This licensing includes compliance both with governing radioactive materials and with those regulations governing pharmaceutical preparations. Additional regulations may apply for issues such as transportation or dispensing of radiopharmaceuticals.

Recent Developments:

Recent trends in the radiopharmaceuticals market such as growing disease which targeted cancer therapy, increasing awareness, expanding applications of molecular imaging, technological advancement, increasing trend of radio-labelled peptides and monoclonal antibodies for the diagnosis and treatment of cancer tumors and increasing use of SPECT & PET scans is expected to drive the market in the forecast period 2017 to 2024.

Any Specific Requirements? Questions? Ask to Our Industry Expert @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-radiopharmaceuticals-market

Overview:

On the basis of type,
• Diagnostic
• Therapeutic radiopharmaceuticals.

On the basis of procedural volumes,
1. Diagnostic procedure
• single-photon emission computed tomography (SPECT) radiopharmaceuticals
• positron emission tomography (PET) radiopharmaceuticals
2. Therapeutic procedures
• beta emitters
• alpha emitters
• brachy therapy

On the basis of application,
1. diagnostic application
• single-photon emission computed tomography (SPECT) -
• positron emission tomography (PET)- oncology, cardiology, neurology and others
2. therapeutic application
• thyroid,
• bone metastasis,
• lymphoma,
• endocrine tumours
• others

On the basis of sources,
• nuclear reactors
• cyclotrons

On the basis of end user,
• hospitals,
• ambulatory surgical centers,
• diagnostic centers,
• cancer research institutes and
• others

In 2017, hospital segment dominate the market with the highest market share due to accessibility of highly skilled medical practitioners in the radiology departments of hospitals.

In 2017, diagnostic radiopharmaceuticals segment dominate the market and is expected to grow at the highest in the forecast period. This is due to the production of MO-99 in the U.S., FDA approvals of radiopharmaceuticals, initiatives of International Atomic Energy Agency (IAEA), new irradiation facility in Germany, installation of PET scanners in India, andgovernment investments in Rest of Asia-Pacific.

Competitive Analysis:

The global radiopharmaceuticals market is fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market in order to sustain in long run. The report includes market shares of security orchestration market for global, Europe, North America, Asia Pacific and South America.

Any Quire? Ask to Experts @ https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-radiopharmaceuticals-market

TABLE OF CONTENTS
1 INTRODUCTION
1.1. OVERVIEW OF THE GLOBAL RADIOPHARMACEUTICALS MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2 MARKET SEGMENTATION
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL RADIOPHARMACEUTICALS SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET TIME LINE
2.2.4 MARKET GUIDE
2.2.5 COMPANY POSITIONING GRID
2.2.6 COMAPANY MARKET SHARE ANALYSIS
2.2.7 MULTIVARIATE MODELLING
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 TOP TO BOTTOM ANALYSIS
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3. GLOBAL RADIOPHARMACEUTICALS MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3 MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1. VENDOR POSITIONING GRID AND INVESTMENT OPPORTUNITIES
5.2. TECHNOLOLGICAL ADVANCEMENTS
5.3. INSIGHTS ON TECHNOLOGICAL DEVELOPMENTS IN THE GLOBAL RADIOPHARMACEUTICALSMARKET
5.4. MARKET REGULATORY SCENARIO BY COUNTRY
5.5. INTERVIEW KEY INSIGHTS
6 GLOBAL RADIOPHARMACEUTICALS MARKET, BY TYPE
7 GLOBAL RADIOPHARMACEUTICALS MARKET, BY PROCEDURAL VOLUMES
8 GLOBAL RADIOPHARMACEUTICALS MARKET, BY APPLICATION
9 GLOBAL RADIOPHARMACEUTICALS MARKET, BY SOURCES
10 GLOBAL RADIOPHARMACEUTICALS MARKET, BY END-USER
11 GLOBAL RADIOPHARMACEUTICALS MARKET, BY GEOGRAPHY
12 GLOBAL RADIOPHARMACEUTICALS MARKET, COMPANY PROFILES
12.1 CARDINAL HEALTH INC.,
12.2 MALLINCKRODTPLC.,
12.3 GE HEALTHCARE,
12.4 LANTHEUS MEDICAL IMAGING INC.,
12.5 BAYER AG,
12.6 COMPANY A
12.7 COMPANY B
12.8 COMPANY C
12.9 COMPANY D
12.10 COMPANY E
12.11 COMPANY F
10.12 COMPANY G
10.13 COMPANY H
10.14 COMPANY I
10.15 COMPANY J
10.16 COMPANY K
10.17 COMPANY M
10.18 COMPANY N
10.19 COMPANY O
11 APPENDIX
12 ABOUT DATA BRIDGE MARKET RESEARCH

Request for Table of Content of Full Report @ https://databridgemarketresearch.com/toc/?dbmr=global-radiopharmaceuticals-market

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.